David Alan Zacharias

Title: Innovations by David Alan Zacharias

Introduction

David Alan Zacharias is an accomplished inventor based in St. Augustine, Florida. He has made significant contributions to the field of medical diagnostics, particularly in the detection of interstitial cystitis. With a total of three patents to his name, his work has the potential to improve the lives of many patients suffering from this condition.

Latest Patents

One of his latest patents is focused on the cell-based detection of antiproliferative factor (APF) through its interaction with cytoskeletal associated protein 4 (CKAP4) for the diagnosis of interstitial cystitis (IC). This innovative assay system is designed to detect a protein biomarker in urine that is diagnostic for IC. The presence of a unique 9 amino acid glycopeptide, APF, in urine is indicative of patients with IC. The assay involves adding urine samples from patients exhibiting symptoms consistent with IC. The binding of APF to CKAP4 confirms the presence of APF in urine, thus providing a diagnostic tool for IC. This diagnostic system represents a significant advancement in the diagnosis of IC and has commercial applications relevant to both women and men suffering from symptoms associated with this condition.

Career Highlights

David has worked with notable organizations such as the University of Florida Research Foundation and The Commonwealth Medical College. His experience in these institutions has contributed to his expertise in medical research and innovation.

Collaborations

Some of his coworkers include Sonia Lobo Planey and Susan K Keay. Their collaboration has likely enhanced the development and implementation of his innovative diagnostic systems.

Conclusion

David Alan Zacharias is a notable inventor whose work in medical diagnostics has the potential to transform the way interstitial cystitis is diagnosed and treated. His innovative approach and dedication to improving patient outcomes are commendable.